0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Hemodialyzer and Hemoperfusion - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-33R13922
Home | Market Reports | Health| Medical Devices & Equipment
Global Hemodialyzer and Hemoperfusion Market Research Report 2023
BUY CHAPTERS

Hemodialyzer and Hemoperfusion - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-33R13922
Report
September 2024
Pages:143
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hemodialyzer and Hemoperfusion - Market Size

The global market for Hemodialyzer and Hemoperfusion was estimated to be worth US$ 1263 million in 2023 and is forecast to a readjusted size of US$ 2035 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030

Hemodialyzer and Hemoperfusion - Market

Hemodialyzer and Hemoperfusion - Market

Blood purification is a treatment in which a patient's blood is passed through a device in which solute (waste products, toxins) and possibly water is removed. With these advances, blood purification as a treatment for human septic shock was born.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hemodialyzer and Hemoperfusion, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hemodialyzer and Hemoperfusion by region & country, by Type, and by Application.
The Hemodialyzer and Hemoperfusion market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemodialyzer and Hemoperfusion.
Market Segmentation

Scope of Hemodialyzer and Hemoperfusion - Market Report

Report Metric Details
Report Name Hemodialyzer and Hemoperfusion - Market
Forecasted market size in 2030 US$ 2035 million
CAGR 7.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Hemodialyzer
  • Hemoperfusion
Segment by Application
  • Dialysis Centers
  • Hospitals
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Fresenius Medical Care, Baxter, Nipro, Asahi Kasei, Toray, B.Braun, Nikkiso, SB-KAWASUM, Medica Group, WEGO Group, Lengthen, Shanghai Peony Medical, Chengdu OCI Medical, Bain Medical Equipment, Jafron Biomedical, Kaneka Medix Corporation, CytoSorbents
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Hemodialyzer and Hemoperfusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Hemodialyzer and Hemoperfusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Hemodialyzer and Hemoperfusion in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Hemodialyzer and Hemoperfusion - Market size in 2030?

Ans: The Hemodialyzer and Hemoperfusion - Market size in 2030 will be US$ 2035 million.

Who are the main players in the Hemodialyzer and Hemoperfusion - Market report?

Ans: The main players in the Hemodialyzer and Hemoperfusion - Market are Fresenius Medical Care, Baxter, Nipro, Asahi Kasei, Toray, B.Braun, Nikkiso, SB-KAWASUM, Medica Group, WEGO Group, Lengthen, Shanghai Peony Medical, Chengdu OCI Medical, Bain Medical Equipment, Jafron Biomedical, Kaneka Medix Corporation, CytoSorbents

What are the Application segmentation covered in the Hemodialyzer and Hemoperfusion - Market report?

Ans: The Applications covered in the Hemodialyzer and Hemoperfusion - Market report are Dialysis Centers, Hospitals, Other

What are the Type segmentation covered in the Hemodialyzer and Hemoperfusion - Market report?

Ans: The Types covered in the Hemodialyzer and Hemoperfusion - Market report are Hemodialyzer, Hemoperfusion

1 Market Overview
1.1 Hemodialyzer and Hemoperfusion Product Introduction
1.2 Global Hemodialyzer and Hemoperfusion Market Size Forecast
1.2.1 Global Hemodialyzer and Hemoperfusion Sales Value (2019-2030)
1.2.2 Global Hemodialyzer and Hemoperfusion Sales Volume (2019-2030)
1.2.3 Global Hemodialyzer and Hemoperfusion Sales Price (2019-2030)
1.3 Hemodialyzer and Hemoperfusion Market Trends & Drivers
1.3.1 Hemodialyzer and Hemoperfusion Industry Trends
1.3.2 Hemodialyzer and Hemoperfusion Market Drivers & Opportunity
1.3.3 Hemodialyzer and Hemoperfusion Market Challenges
1.3.4 Hemodialyzer and Hemoperfusion Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hemodialyzer and Hemoperfusion Players Revenue Ranking (2023)
2.2 Global Hemodialyzer and Hemoperfusion Revenue by Company (2019-2024)
2.3 Global Hemodialyzer and Hemoperfusion Players Sales Volume Ranking (2023)
2.4 Global Hemodialyzer and Hemoperfusion Sales Volume by Company Players (2019-2024)
2.5 Global Hemodialyzer and Hemoperfusion Average Price by Company (2019-2024)
2.6 Key Manufacturers Hemodialyzer and Hemoperfusion Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Hemodialyzer and Hemoperfusion Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hemodialyzer and Hemoperfusion
2.9 Hemodialyzer and Hemoperfusion Market Competitive Analysis
2.9.1 Hemodialyzer and Hemoperfusion Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Hemodialyzer and Hemoperfusion Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemodialyzer and Hemoperfusion as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hemodialyzer
3.1.2 Hemoperfusion
3.2 Global Hemodialyzer and Hemoperfusion Sales Value by Type
3.2.1 Global Hemodialyzer and Hemoperfusion Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Hemodialyzer and Hemoperfusion Sales Value, by Type (2019-2030)
3.2.3 Global Hemodialyzer and Hemoperfusion Sales Value, by Type (%) (2019-2030)
3.3 Global Hemodialyzer and Hemoperfusion Sales Volume by Type
3.3.1 Global Hemodialyzer and Hemoperfusion Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Hemodialyzer and Hemoperfusion Sales Volume, by Type (2019-2030)
3.3.3 Global Hemodialyzer and Hemoperfusion Sales Volume, by Type (%) (2019-2030)
3.4 Global Hemodialyzer and Hemoperfusion Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Dialysis Centers
4.1.2 Hospitals
4.1.3 Other
4.2 Global Hemodialyzer and Hemoperfusion Sales Value by Application
4.2.1 Global Hemodialyzer and Hemoperfusion Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Hemodialyzer and Hemoperfusion Sales Value, by Application (2019-2030)
4.2.3 Global Hemodialyzer and Hemoperfusion Sales Value, by Application (%) (2019-2030)
4.3 Global Hemodialyzer and Hemoperfusion Sales Volume by Application
4.3.1 Global Hemodialyzer and Hemoperfusion Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Hemodialyzer and Hemoperfusion Sales Volume, by Application (2019-2030)
4.3.3 Global Hemodialyzer and Hemoperfusion Sales Volume, by Application (%) (2019-2030)
4.4 Global Hemodialyzer and Hemoperfusion Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Hemodialyzer and Hemoperfusion Sales Value by Region
5.1.1 Global Hemodialyzer and Hemoperfusion Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Hemodialyzer and Hemoperfusion Sales Value by Region (2019-2024)
5.1.3 Global Hemodialyzer and Hemoperfusion Sales Value by Region (2025-2030)
5.1.4 Global Hemodialyzer and Hemoperfusion Sales Value by Region (%), (2019-2030)
5.2 Global Hemodialyzer and Hemoperfusion Sales Volume by Region
5.2.1 Global Hemodialyzer and Hemoperfusion Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Hemodialyzer and Hemoperfusion Sales Volume by Region (2019-2024)
5.2.3 Global Hemodialyzer and Hemoperfusion Sales Volume by Region (2025-2030)
5.2.4 Global Hemodialyzer and Hemoperfusion Sales Volume by Region (%), (2019-2030)
5.3 Global Hemodialyzer and Hemoperfusion Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Hemodialyzer and Hemoperfusion Sales Value, 2019-2030
5.4.2 North America Hemodialyzer and Hemoperfusion Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Hemodialyzer and Hemoperfusion Sales Value, 2019-2030
5.5.2 Europe Hemodialyzer and Hemoperfusion Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Hemodialyzer and Hemoperfusion Sales Value, 2019-2030
5.6.2 Asia Pacific Hemodialyzer and Hemoperfusion Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Hemodialyzer and Hemoperfusion Sales Value, 2019-2030
5.7.2 South America Hemodialyzer and Hemoperfusion Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hemodialyzer and Hemoperfusion Sales Value, 2019-2030
5.8.2 Middle East & Africa Hemodialyzer and Hemoperfusion Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hemodialyzer and Hemoperfusion Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Hemodialyzer and Hemoperfusion Sales Value
6.2.1 Key Countries/Regions Hemodialyzer and Hemoperfusion Sales Value, 2019-2030
6.2.2 Key Countries/Regions Hemodialyzer and Hemoperfusion Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Hemodialyzer and Hemoperfusion Sales Value, 2019-2030
6.3.2 United States Hemodialyzer and Hemoperfusion Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Hemodialyzer and Hemoperfusion Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Hemodialyzer and Hemoperfusion Sales Value, 2019-2030
6.4.2 Europe Hemodialyzer and Hemoperfusion Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Hemodialyzer and Hemoperfusion Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Hemodialyzer and Hemoperfusion Sales Value, 2019-2030
6.5.2 China Hemodialyzer and Hemoperfusion Sales Value by Type (%), 2023 VS 2030
6.5.3 China Hemodialyzer and Hemoperfusion Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Hemodialyzer and Hemoperfusion Sales Value, 2019-2030
6.6.2 Japan Hemodialyzer and Hemoperfusion Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Hemodialyzer and Hemoperfusion Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Hemodialyzer and Hemoperfusion Sales Value, 2019-2030
6.7.2 South Korea Hemodialyzer and Hemoperfusion Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Hemodialyzer and Hemoperfusion Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Hemodialyzer and Hemoperfusion Sales Value, 2019-2030
6.8.2 Southeast Asia Hemodialyzer and Hemoperfusion Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Hemodialyzer and Hemoperfusion Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Hemodialyzer and Hemoperfusion Sales Value, 2019-2030
6.9.2 India Hemodialyzer and Hemoperfusion Sales Value by Type (%), 2023 VS 2030
6.9.3 India Hemodialyzer and Hemoperfusion Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Fresenius Medical Care
7.1.1 Fresenius Medical Care Company Information
7.1.2 Fresenius Medical Care Introduction and Business Overview
7.1.3 Fresenius Medical Care Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Fresenius Medical Care Hemodialyzer and Hemoperfusion Product Offerings
7.1.5 Fresenius Medical Care Recent Development
7.2 Baxter
7.2.1 Baxter Company Information
7.2.2 Baxter Introduction and Business Overview
7.2.3 Baxter Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Baxter Hemodialyzer and Hemoperfusion Product Offerings
7.2.5 Baxter Recent Development
7.3 Nipro
7.3.1 Nipro Company Information
7.3.2 Nipro Introduction and Business Overview
7.3.3 Nipro Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Nipro Hemodialyzer and Hemoperfusion Product Offerings
7.3.5 Nipro Recent Development
7.4 Asahi Kasei
7.4.1 Asahi Kasei Company Information
7.4.2 Asahi Kasei Introduction and Business Overview
7.4.3 Asahi Kasei Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Asahi Kasei Hemodialyzer and Hemoperfusion Product Offerings
7.4.5 Asahi Kasei Recent Development
7.5 Toray
7.5.1 Toray Company Information
7.5.2 Toray Introduction and Business Overview
7.5.3 Toray Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Toray Hemodialyzer and Hemoperfusion Product Offerings
7.5.5 Toray Recent Development
7.6 B.Braun
7.6.1 B.Braun Company Information
7.6.2 B.Braun Introduction and Business Overview
7.6.3 B.Braun Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.6.4 B.Braun Hemodialyzer and Hemoperfusion Product Offerings
7.6.5 B.Braun Recent Development
7.7 Nikkiso
7.7.1 Nikkiso Company Information
7.7.2 Nikkiso Introduction and Business Overview
7.7.3 Nikkiso Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Nikkiso Hemodialyzer and Hemoperfusion Product Offerings
7.7.5 Nikkiso Recent Development
7.8 SB-KAWASUM
7.8.1 SB-KAWASUM Company Information
7.8.2 SB-KAWASUM Introduction and Business Overview
7.8.3 SB-KAWASUM Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.8.4 SB-KAWASUM Hemodialyzer and Hemoperfusion Product Offerings
7.8.5 SB-KAWASUM Recent Development
7.9 Medica Group
7.9.1 Medica Group Company Information
7.9.2 Medica Group Introduction and Business Overview
7.9.3 Medica Group Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Medica Group Hemodialyzer and Hemoperfusion Product Offerings
7.9.5 Medica Group Recent Development
7.10 WEGO Group
7.10.1 WEGO Group Company Information
7.10.2 WEGO Group Introduction and Business Overview
7.10.3 WEGO Group Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.10.4 WEGO Group Hemodialyzer and Hemoperfusion Product Offerings
7.10.5 WEGO Group Recent Development
7.11 Lengthen
7.11.1 Lengthen Company Information
7.11.2 Lengthen Introduction and Business Overview
7.11.3 Lengthen Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Lengthen Hemodialyzer and Hemoperfusion Product Offerings
7.11.5 Lengthen Recent Development
7.12 Shanghai Peony Medical
7.12.1 Shanghai Peony Medical Company Information
7.12.2 Shanghai Peony Medical Introduction and Business Overview
7.12.3 Shanghai Peony Medical Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Shanghai Peony Medical Hemodialyzer and Hemoperfusion Product Offerings
7.12.5 Shanghai Peony Medical Recent Development
7.13 Chengdu OCI Medical
7.13.1 Chengdu OCI Medical Company Information
7.13.2 Chengdu OCI Medical Introduction and Business Overview
7.13.3 Chengdu OCI Medical Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Chengdu OCI Medical Hemodialyzer and Hemoperfusion Product Offerings
7.13.5 Chengdu OCI Medical Recent Development
7.14 Bain Medical Equipment
7.14.1 Bain Medical Equipment Company Information
7.14.2 Bain Medical Equipment Introduction and Business Overview
7.14.3 Bain Medical Equipment Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Bain Medical Equipment Hemodialyzer and Hemoperfusion Product Offerings
7.14.5 Bain Medical Equipment Recent Development
7.15 Jafron Biomedical
7.15.1 Jafron Biomedical Company Information
7.15.2 Jafron Biomedical Introduction and Business Overview
7.15.3 Jafron Biomedical Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Jafron Biomedical Hemodialyzer and Hemoperfusion Product Offerings
7.15.5 Jafron Biomedical Recent Development
7.16 Kaneka Medix Corporation
7.16.1 Kaneka Medix Corporation Company Information
7.16.2 Kaneka Medix Corporation Introduction and Business Overview
7.16.3 Kaneka Medix Corporation Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Kaneka Medix Corporation Hemodialyzer and Hemoperfusion Product Offerings
7.16.5 Kaneka Medix Corporation Recent Development
7.17 CytoSorbents
7.17.1 CytoSorbents Company Information
7.17.2 CytoSorbents Introduction and Business Overview
7.17.3 CytoSorbents Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.17.4 CytoSorbents Hemodialyzer and Hemoperfusion Product Offerings
7.17.5 CytoSorbents Recent Development
8 Industry Chain Analysis
8.1 Hemodialyzer and Hemoperfusion Industrial Chain
8.2 Hemodialyzer and Hemoperfusion Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hemodialyzer and Hemoperfusion Sales Model
8.5.2 Sales Channel
8.5.3 Hemodialyzer and Hemoperfusion Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Hemodialyzer and Hemoperfusion Market Trends
    Table 2. Hemodialyzer and Hemoperfusion Market Drivers & Opportunity
    Table 3. Hemodialyzer and Hemoperfusion Market Challenges
    Table 4. Hemodialyzer and Hemoperfusion Market Restraints
    Table 5. Global Hemodialyzer and Hemoperfusion Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Hemodialyzer and Hemoperfusion Revenue Market Share by Company (2019-2024)
    Table 7. Global Hemodialyzer and Hemoperfusion Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Hemodialyzer and Hemoperfusion Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Hemodialyzer and Hemoperfusion Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Hemodialyzer and Hemoperfusion Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Hemodialyzer and Hemoperfusion Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Hemodialyzer and Hemoperfusion
    Table 13. Global Hemodialyzer and Hemoperfusion Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemodialyzer and Hemoperfusion as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Hemodialyzer and Hemoperfusion Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Hemodialyzer and Hemoperfusion Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Hemodialyzer and Hemoperfusion Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Hemodialyzer and Hemoperfusion Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Hemodialyzer and Hemoperfusion Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Hemodialyzer and Hemoperfusion Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Hemodialyzer and Hemoperfusion Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Hemodialyzer and Hemoperfusion Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Hemodialyzer and Hemoperfusion Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Hemodialyzer and Hemoperfusion Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Hemodialyzer and Hemoperfusion Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Hemodialyzer and Hemoperfusion Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Hemodialyzer and Hemoperfusion Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Hemodialyzer and Hemoperfusion Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Hemodialyzer and Hemoperfusion Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Hemodialyzer and Hemoperfusion Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Hemodialyzer and Hemoperfusion Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Hemodialyzer and Hemoperfusion Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Hemodialyzer and Hemoperfusion Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Hemodialyzer and Hemoperfusion Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Hemodialyzer and Hemoperfusion Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Hemodialyzer and Hemoperfusion Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Hemodialyzer and Hemoperfusion Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Hemodialyzer and Hemoperfusion Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Hemodialyzer and Hemoperfusion Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Hemodialyzer and Hemoperfusion Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Hemodialyzer and Hemoperfusion Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Hemodialyzer and Hemoperfusion Sales Value by Region (2019-2024) & (%)
    Table 44. Global Hemodialyzer and Hemoperfusion Sales Value by Region (2025-2030) & (%)
    Table 45. Global Hemodialyzer and Hemoperfusion Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Hemodialyzer and Hemoperfusion Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Hemodialyzer and Hemoperfusion Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Hemodialyzer and Hemoperfusion Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Hemodialyzer and Hemoperfusion Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Hemodialyzer and Hemoperfusion Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Hemodialyzer and Hemoperfusion Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Hemodialyzer and Hemoperfusion Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Hemodialyzer and Hemoperfusion Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Hemodialyzer and Hemoperfusion Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Hemodialyzer and Hemoperfusion Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Hemodialyzer and Hemoperfusion Sales Volume, (2025-2030) & (K Units)
    Table 57. Fresenius Medical Care Company Information
    Table 58. Fresenius Medical Care Introduction and Business Overview
    Table 59. Fresenius Medical Care Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Fresenius Medical Care Hemodialyzer and Hemoperfusion Product Offerings
    Table 61. Fresenius Medical Care Recent Development
    Table 62. Baxter Company Information
    Table 63. Baxter Introduction and Business Overview
    Table 64. Baxter Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Baxter Hemodialyzer and Hemoperfusion Product Offerings
    Table 66. Baxter Recent Development
    Table 67. Nipro Company Information
    Table 68. Nipro Introduction and Business Overview
    Table 69. Nipro Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Nipro Hemodialyzer and Hemoperfusion Product Offerings
    Table 71. Nipro Recent Development
    Table 72. Asahi Kasei Company Information
    Table 73. Asahi Kasei Introduction and Business Overview
    Table 74. Asahi Kasei Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Asahi Kasei Hemodialyzer and Hemoperfusion Product Offerings
    Table 76. Asahi Kasei Recent Development
    Table 77. Toray Company Information
    Table 78. Toray Introduction and Business Overview
    Table 79. Toray Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Toray Hemodialyzer and Hemoperfusion Product Offerings
    Table 81. Toray Recent Development
    Table 82. B.Braun Company Information
    Table 83. B.Braun Introduction and Business Overview
    Table 84. B.Braun Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. B.Braun Hemodialyzer and Hemoperfusion Product Offerings
    Table 86. B.Braun Recent Development
    Table 87. Nikkiso Company Information
    Table 88. Nikkiso Introduction and Business Overview
    Table 89. Nikkiso Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Nikkiso Hemodialyzer and Hemoperfusion Product Offerings
    Table 91. Nikkiso Recent Development
    Table 92. SB-KAWASUM Company Information
    Table 93. SB-KAWASUM Introduction and Business Overview
    Table 94. SB-KAWASUM Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. SB-KAWASUM Hemodialyzer and Hemoperfusion Product Offerings
    Table 96. SB-KAWASUM Recent Development
    Table 97. Medica Group Company Information
    Table 98. Medica Group Introduction and Business Overview
    Table 99. Medica Group Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Medica Group Hemodialyzer and Hemoperfusion Product Offerings
    Table 101. Medica Group Recent Development
    Table 102. WEGO Group Company Information
    Table 103. WEGO Group Introduction and Business Overview
    Table 104. WEGO Group Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. WEGO Group Hemodialyzer and Hemoperfusion Product Offerings
    Table 106. WEGO Group Recent Development
    Table 107. Lengthen Company Information
    Table 108. Lengthen Introduction and Business Overview
    Table 109. Lengthen Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Lengthen Hemodialyzer and Hemoperfusion Product Offerings
    Table 111. Lengthen Recent Development
    Table 112. Shanghai Peony Medical Company Information
    Table 113. Shanghai Peony Medical Introduction and Business Overview
    Table 114. Shanghai Peony Medical Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Shanghai Peony Medical Hemodialyzer and Hemoperfusion Product Offerings
    Table 116. Shanghai Peony Medical Recent Development
    Table 117. Chengdu OCI Medical Company Information
    Table 118. Chengdu OCI Medical Introduction and Business Overview
    Table 119. Chengdu OCI Medical Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Chengdu OCI Medical Hemodialyzer and Hemoperfusion Product Offerings
    Table 121. Chengdu OCI Medical Recent Development
    Table 122. Bain Medical Equipment Company Information
    Table 123. Bain Medical Equipment Introduction and Business Overview
    Table 124. Bain Medical Equipment Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Bain Medical Equipment Hemodialyzer and Hemoperfusion Product Offerings
    Table 126. Bain Medical Equipment Recent Development
    Table 127. Jafron Biomedical Company Information
    Table 128. Jafron Biomedical Introduction and Business Overview
    Table 129. Jafron Biomedical Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Jafron Biomedical Hemodialyzer and Hemoperfusion Product Offerings
    Table 131. Jafron Biomedical Recent Development
    Table 132. Kaneka Medix Corporation Company Information
    Table 133. Kaneka Medix Corporation Introduction and Business Overview
    Table 134. Kaneka Medix Corporation Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Kaneka Medix Corporation Hemodialyzer and Hemoperfusion Product Offerings
    Table 136. Kaneka Medix Corporation Recent Development
    Table 137. CytoSorbents Company Information
    Table 138. CytoSorbents Introduction and Business Overview
    Table 139. CytoSorbents Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. CytoSorbents Hemodialyzer and Hemoperfusion Product Offerings
    Table 141. CytoSorbents Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Hemodialyzer and Hemoperfusion Downstream Customers
    Table 145. Hemodialyzer and Hemoperfusion Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hemodialyzer and Hemoperfusion Product Picture
    Figure 2. Global Hemodialyzer and Hemoperfusion Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Hemodialyzer and Hemoperfusion Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Hemodialyzer and Hemoperfusion Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Hemodialyzer and Hemoperfusion Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Hemodialyzer and Hemoperfusion Report Years Considered
    Figure 7. Global Hemodialyzer and Hemoperfusion Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Hemodialyzer and Hemoperfusion Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hemodialyzer and Hemoperfusion Revenue in 2023
    Figure 10. Hemodialyzer and Hemoperfusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Hemodialyzer Picture
    Figure 12. Hemoperfusion Picture
    Figure 13. Global Hemodialyzer and Hemoperfusion Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Hemodialyzer and Hemoperfusion Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Hemodialyzer and Hemoperfusion Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Hemodialyzer and Hemoperfusion Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Hemodialyzer and Hemoperfusion Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Dialysis Centers
    Figure 19. Product Picture of Hospitals
    Figure 20. Product Picture of Other
    Figure 21. Global Hemodialyzer and Hemoperfusion Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Hemodialyzer and Hemoperfusion Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Hemodialyzer and Hemoperfusion Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Hemodialyzer and Hemoperfusion Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Hemodialyzer and Hemoperfusion Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America Hemodialyzer and Hemoperfusion Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Hemodialyzer and Hemoperfusion Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Hemodialyzer and Hemoperfusion Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Hemodialyzer and Hemoperfusion Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Hemodialyzer and Hemoperfusion Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Hemodialyzer and Hemoperfusion Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Hemodialyzer and Hemoperfusion Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Hemodialyzer and Hemoperfusion Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Hemodialyzer and Hemoperfusion Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Hemodialyzer and Hemoperfusion Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Hemodialyzer and Hemoperfusion Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Hemodialyzer and Hemoperfusion Sales Volume (%), (2019-2030)
    Figure 38. United States Hemodialyzer and Hemoperfusion Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Hemodialyzer and Hemoperfusion Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Hemodialyzer and Hemoperfusion Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Hemodialyzer and Hemoperfusion Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Hemodialyzer and Hemoperfusion Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Hemodialyzer and Hemoperfusion Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Hemodialyzer and Hemoperfusion Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Hemodialyzer and Hemoperfusion Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Hemodialyzer and Hemoperfusion Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Hemodialyzer and Hemoperfusion Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Hemodialyzer and Hemoperfusion Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Hemodialyzer and Hemoperfusion Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Hemodialyzer and Hemoperfusion Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Hemodialyzer and Hemoperfusion Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Hemodialyzer and Hemoperfusion Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Hemodialyzer and Hemoperfusion Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Hemodialyzer and Hemoperfusion Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Hemodialyzer and Hemoperfusion Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Hemodialyzer and Hemoperfusion Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Hemodialyzer and Hemoperfusion Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Hemodialyzer and Hemoperfusion Sales Value by Application (%), 2023 VS 2030
    Figure 59. Hemodialyzer and Hemoperfusion Industrial Chain
    Figure 60. Hemodialyzer and Hemoperfusion Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Electrosurgical Cutting Electrode Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-18M7037
Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Treatment Trolleys Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-7B8751
Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Monopolar Cutting Electrosurgical Unit Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-2L7328
Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Cutting Electrosurgical Unit Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-35P6799
Sat Oct 12 00:00:00 UTC 2024

Add to Cart